Joshua I Barzilay

Prof. Joshua I Barzilay


Research Focus & Metrics

Academic Career Length

30Years (1997-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 October 2001 in Diabetes
Verified
Journal Article
Closed access
PDF file
JBJoshua I Barzilay
Joshua I Barzilay
LALinn Abraham
Linn Abraham
SHSusan R. Heckbert
Susan R. Heckbert
MCMary Cushman
Mary Cushman
LKLewis H. Kuller
Lewis H. Kuller
RTRussell P. Tracy
Russell P. Tracy
Several studies suggest that inflammation plays a role in the pathogenesis of some glucose disorders in adults. We tested this hypothesis in a longitudinal cohort study of older individuals who had normal fasting glucose (FG) values at baseline. We compared the baseline levels of six inflammatory markers in participants who had developed glucose disorders at follow-up with those of participants whose FG remained normal at follow-up. Participants were members of the Cardiovascular Health Study, a prospective study of risk factors for cardiovascular disease in adults ≥65 years. All 5,888 participants had baseline testing, including FG and markers of inflammation: white blood cell and platelet counts and albumin, fibrinogen, C-reactive protein (CRP), and factor VIIIc levels. At 3–4 years of follow-up, 4,481 (84.5%) of those who were alive had FG levels retested. Participants who developed diabetes (n = 45) had higher median levels of CRP at baseline than those who remained normoglycemic. On multivariate analysis, those with elevated CRP levels (75th percentile [2.86 mg/l] vs. 25th percentile [0.82 mg/l]) were 2.03 times (95% confidence intervals, 1.44–2.86) more likely to have diabetes on follow-up. Adjustment for confounders and other inflammatory markers did not appreciably change this finding. There was no relationship between the development of diabetes and other markers of inflammation. Inflammation, as measured by CRP levels, is associated with the development of diabetes in the elderly. Understanding the role of inflammation in the pathogenesis of glucose disorders in this age-group may lead to better classification and treatment of glucose disorders among them.

9 April 2007 in Archives of internal medicine (1960)
Verified
Journal Article
Open access
PDF file
JBJoshua I Barzilay
Joshua I Barzilay
CBCaroline Blaum
Caroline Blaum
TMTisha Moore
Tisha Moore
QXQian Li Xue
Qian Li Xue
CHCalvin H. Hirsch
Calvin H. Hirsch
LFLinda P. Fried
Linda P. Fried
The geriatric syndrome of frailty is characterized by decreased reserve in multiple physiologic systems.1 It predicts adverse health outcomes independent of advancing age, chronic disease, and functional limitations, thereby suggesting that it is a distinct condition.2-4 Using data from the Cardiovascular Health Study (CHS)5 and the Women's Heath and Aging Studies,6 our research group tested and validated the hypothesis that frailty could be defined as a syndrome consisting of involuntary weight loss, exhaustion, low physical activity, slowness, and weakness. Subsequently, a physiologic basis for this phenotype was explored.7 On cross-sectional analysis, frailty was associated with adiposity, altered markers of carbohydrate metabolism, hypertension, and elevated markers of inflammation and coagulation. All of these findings are characteristics of the metabolic syndrome (MetS).8

16 January 2024 in Journal of the American Heart Association
Verified
Journal Article
Open access
JBJoshua I Barzilay
Joshua I Barzilay
YFYoussef M. K. Farag
Youssef M. K. Farag
JDJeffrey Durthaler
Jeffrey Durthaler
Albuminuria, an established biomarker of the progression of chronic kidney disease, is also recognized as a biomarker for the risk of cardiovascular disease. Elevated urinary albumin excretion indicates kidney damage and systemic vascular disease, including myocardial capillary disease and arterial stiffness. Albuminuria is associated with an increased risk of coronary artery disease, stroke, heart failure, arrhythmias, and microvascular disease. There are now several therapeutic agents that can lead to albuminuria lowering and a reduction in cardiovascular risk. However, screening for albuminuria is still low. Considering the importance of multidisciplinary management of patients with cardiovascular disease, it is crucial that health care professionals managing such patients are aware of the benefits of albuminuria surveillance and management.

1 August 1999 in The Lancet
Verified
Journal Article
Closed access
JBJoshua I Barzilay
Joshua I Barzilay
CSCharles F Spiekerman
Charles F Spiekerman
PWPatricia W Wahl
Patricia W Wahl
LKLewis H Kuller
Lewis H Kuller
MCMary Cushman
Mary Cushman
PSPeter J Savage
Peter J Savage

26 January 2009 in Diabetes Care
Verified
Journal Article
Open access
JBJoshua I Barzilay
Joshua I Barzilay
GCGeorge A. Cotsonis
George A. Cotsonis
JWJeremy Walston
Jeremy Walston
ASAnn V. Schwartz
Ann V. Schwartz
SSSuzanne Satterfield
Suzanne Satterfield
FSfor the Health ABC Study
for the Health ABC Study
OBJECTIVE: Lower-limb muscle strength is reduced in many people with diabetes. In this study, we examined whether quadriceps muscle strength is reduced in relation to insulin resistance in well-functioning ambulatory nondiabetic individuals. RESEARCH DESIGN AND METHODS: Participants (age ≥70 years) underwent dual-energy X-ray absorptiometry (DEXA) scanning to ascertain muscle and fat mass, tests of quadriceps strength, computed tomography scanning of the quadriceps to gauge muscle lipid content, and fasting insulin and glucose level measurements from which homeostasis model assessment of insulin resistance (HOMA-IR) was derived. RESULTS: In regression analysis, quadriceps strength per kilogram of muscle mass was negatively associated (P < 0.0001) with HOMA-IR independent of other factors negatively associated with strength such as increased age, female sex, low-physical activity, impaired fasting glucose, and increased total body fat. Muscle lipid content was not associated with strength. CONCLUSIONS: A small decrease in quadriceps muscle force is associated with increased HOMA-IR in well-functioning nondiabetic adults, suggesting that diminished quadriceps muscle strength begins before diabetes.

1 July 2004 in American Journal of Kidney Diseases
Verified
Journal Article
Closed access
PDF file
JBJoshua I Barzilay
Joshua I Barzilay
DPDo Peterson
Do Peterson
MCMary Cushman
Mary Cushman
SHSusan R Heckbert
Susan R Heckbert
JCJie J Cao
Jie J Cao
DHDavid M Herrington
David M Herrington